Remove Cannabinoids Remove Cannabis Remove Clinical Trials Remove THC
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

article thumbnail

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. These opioid-sparing effects were most pronounced among participants who had prior experience with cannabis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clinical Trial Explores CBD’s Influence on Cannabis Safety

Veriheal

A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. . of the planet’s population , consuming cannabis annually.

article thumbnail

Cancer patients medicate with cannabis with or without clinical trials

Cannabis Life Network

Every year sees a pile of scientific research supporting the use of cannabis as a treatment for cancer. Clinical evidence, however, has yet prove that cannabinoids, terpenes, or cannabis treat cancer. 1, 2) Before legalization in […]. 1, 2) Before legalization in […].

article thumbnail

Cannabinoids for Tinnitus?

Project CBD

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. Among the 45 respondents, median age 55, only 10 said they were current cannabis users (19 had never used, and 16 had used in the past).

article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

article thumbnail

THC & CBD-Rich Cannabis for Fibromyalgia

Project CBD

But there’s another option that can address mood, pain, and more at once, all with fewer side effects: cannabis. Nor is it necessarily surprising, given the ability of cannabis to target the ubiquitous, homeostasis-seeking endocannabinoid system. It’s not a new idea.

THC 144